AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NUTRITIONAL GROWTH SOLUTIONS

0.020

-0.002-9.09%

Volume:25.00K

Turnover:500.00

Market Cap:6.66M

PE:-0.47

High:0.020

Open:0.020

Low:0.020

Close:0.022

52wk High:0.036

52wk Low:0.017

Shares:333.09M

Float Shares:107.93M

Volume Ratio:8.33

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.042

EPS(LYR):-0.059

ROE:-304.85%

ROA:-257.85%

PB:-2.68

PE(LYR):-0.34

Loading ...

Overview Company News Filings

Gene Solutions and Pangea Laboratory Establish Strategic Collaboration to Validate Laboratory Developed ctDNA Tests for Precision Screening and Cancer Care in the U.S.

BRIEF-Nutritional Growth Solutions Says Appointment Of Interim CEO

Nutritional Growth Solutions Ltd - Stephen J. Turner Will Depart From His Role as CEO and Managing Director

THOMSON REUTERS

Nutritional Growth Solutions Ltd-Md & CEO Departure and Appointment of Interim CEO

THOMSON REUTERS

SPOT-MAS Launches in Taiwan: AI-Powered Multi-Cancer Early Detection Ushers in a New Era of Precision Medicine

Nutritional Growth Solutions Announces A$2M Share Placement

Nutritional Growth Solutions Ltd-Appointment of New Directors & Expansion of Ngs' Board

THOMSON REUTERS

AI and Multi-omics are Transforming Cancer Care: APAC Precision Oncology Conference Outlines the Future of Early Detection and Personalized Treatment

MP Group: Driving Health Innovation and Excellence

BRIEF-Nutritional Growth Solutions Announces A$2M Share Placement

Nutritional Growth Solutions Ltd-Proposed Issue of Securities - Ngs

THOMSON REUTERS

Nutritional Growth Solutions Ltd-Commitments Received for $2M Share Placement

THOMSON REUTERS

Nutritional Growth Solutions Ltd-Quarterly Activities/Appendix 4C Cash Flow Report

THOMSON REUTERS

BRIEF-Nutritional Growth Solutions Seeks Trading Halt Pending Capital Raising Announcement

Nutritional Growth Solutions Ltd-Trading Halt

THOMSON REUTERS

Raffles Medical Group Partners Gene Solutions to Expand Access to Global Cancer Clinical Trials

Twist Bioscience (TWST): Assessing Valuation After New Sequencing Workflow Collaboration With Element Biosciences

Simply Wall St.

Gene Solutions Brings Insights on Advances in MRD and Multi-Omics Technologies to the Singapore Society of Oncology Annual Scientific Meeting 2025

How Investors Are Reacting To Twist Bioscience (TWST) Gaining Exclusive Access to Advanced Sequencing Workflow

Simply Wall St.

Gene Solutions and AMPATH Launch Advanced Genomics Laboratory in Hyderabad to Expand Access to Precision Medicine in India

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NGS.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NGS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NGS.AU\",,,,,undefined,":{"symbol":"NGS.AU","market":"AU","secType":"STK","nameCN":"NUTRITIONAL GROWTH SOLUTIONS","latestPrice":0.02,"timestamp":1770700320000,"preClose":0.022,"halted":0,"volume":25000,"delay":0,"changeRate":-0.09090909090909084,"nameEN":"NUTRITIONAL GROWTH SOLUTIONS","floatShares":107925515,"shares":333093207,"eps":-0.042270833421635984,"marketStatus":"Not Yet Opened","change":-0.002,"latestTime":"02-10 16:12:00 AEDT","open":0.02,"high":0.02,"low":0.02,"amount":500,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.042270833421635984,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.022,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":8.333888703676546,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NGS.AU\",,,,,undefined,":{"symbol":"NGS.AU","floatShares":107925515,"roa":"-257.85%","roe":"-304.85%","lyrEps":-0.05949,"volumeRatio":8.333888703676546,"shares":333093207,"dividePrice":0,"high":0.02,"amplitude":0,"preClose":0.022,"low":0.02,"week52Low":0.017,"pbRate":"-2.68","psRate":"2.24","week52High":0.036,"institutionHeld":0,"latestPrice":0.02,"eps":-0.04227835973699494,"divideRate":0,"volume":25000,"delay":0,"ttmEps":-0.04227835973699494,"open":0.02,"prevYearClose":0.022,"prevWeekClose":0.022,"prevMonthClose":0.02,"prevQuarterClose":0.022,"fiveDayClose":0.022,"twentyDayClose":0.022,"sixtyDayClose":0.019},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NGS.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-07-25","symbol":"NGS.AU","defaultRemindTime":1721865600000,"type":"split","dateTimestamp":1721829600000,"forFactor":10,"toFactor":1,"ratio":10},{"date":"2022-07-28","symbol":"NGS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1658966400000,"name":null,"time":"","dateTimestamp":1658930400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NGS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NGS.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2605123766","title":"Gene Solutions and Pangea Laboratory Establish Strategic Collaboration to Validate Laboratory Developed ctDNA Tests for Precision Screening and Cancer Care in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2605123766","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605123766?lang=en_us&edition=fundamental","pubTime":"2026-01-21 09:00","pubTimestamp":1768957200,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Jan. 21, 2026 /PRNewswire/ -- Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation Sequencing  leader in validation platforms for Laboratory Developed Tests , announced a strategic collaboration to advance U.S. verification and clinical validation of liquid biopsy assays designed for cancer detection, profiling, and monitoring.From left to right: John Moore, CEO of Pangea Laboratory, and Keng-Hou Hsu, Chief Financial Officer of Gene Solutions. Under the agreement, Gene Solutions will provide SOPs, funding, and technical support from its CAP-accredited NGS laboratories in Singapore and Vietnam. Pangea Laboratory will oversee all analytical and clinical validation of Gene Solutions' tests at its U.S. facilities in Irvine, California. The collaboration is to streamline U.S. readiness for Gene Solutions' AI-powered multi-omics liquid biopsy technologies within CLIA/CAP quality systems.The first collaboration","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2865094/Pangea_Laboratory_Gene_Solutions_Teams.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2865094/Pangea_Laboratory_Gene_Solutions_Teams.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/gene-solutions-and-pangea-laboratory-establish-strategic-collaboration-to-validate-laboratory-developed-ctdna-tests-for-precision-screening-and-cancer-care-in-the-us-302665551.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGS","MRD.AU","BK4179","BK7111","BK7095","NGS.AU"],"gpt_icon":0},{"id":"2593472854","title":"BRIEF-Nutritional Growth Solutions Says Appointment Of Interim CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2593472854","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593472854?lang=en_us&edition=fundamental","pubTime":"2025-12-24 09:54","pubTimestamp":1766541296,"startTime":"0","endTime":"0","summary":"BRIEF-Nutritional Growth Solutions Says Appointment Of Interim CEODec 24  - Nutritional Growth Solutions Ltd NGS.AX:MD & CEO DEPARTURE AND APPOINTMENT OF INTERIM CEOSTEPHEN J. TURNER WILL DEPART FROM HIS ROLE AS CEO AND MANAGING DIRECTORANDREW GROVER APPOINTED AS INTERIM CEOFurther company coverage: NGS.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251224:nTUE1XNBF3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGS.AU","BK7111"],"gpt_icon":0},{"id":"2593443534","title":"Nutritional Growth Solutions Ltd - Stephen J. Turner Will Depart From His Role as CEO and Managing Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2593443534","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593443534?lang=en_us&edition=fundamental","pubTime":"2025-12-24 05:16","pubTimestamp":1766524606,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nTUE1XNBF3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGS.AU","BK7111"],"gpt_icon":0},{"id":"2593044330","title":"Nutritional Growth Solutions Ltd-Md & CEO Departure and Appointment of Interim CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2593044330","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593044330?lang=en_us&edition=fundamental","pubTime":"2025-12-24 05:16","pubTimestamp":1766524606,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nTUE1XNBF3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGS.AU","BK7111"],"gpt_icon":0},{"id":"2586810202","title":"SPOT-MAS Launches in Taiwan: AI-Powered Multi-Cancer Early Detection Ushers in a New Era of Precision Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2586810202","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586810202?lang=en_us&edition=fundamental","pubTime":"2025-11-28 16:03","pubTimestamp":1764316980,"startTime":"0","endTime":"0","summary":"TAIPEI, Nov. 28, 2025 /PRNewswire/ -- Precision medicine is entering a new era, driven by breakthroughs in genetic technology and Artificial Intelligence . Multi-Cancer Early Detection has become a global trend, and Taiwan joins this movement with the introduction of SPOT-MAS - an advanced screening solution developed by Gene Solutions, a global leader in precision oncology and genomics, in collaboration with local partner Gene Health.The launch event, \"Gene Solutions  Decoding Tomorrow - SPOT-MASTaiwan Launch & Sharing Session,\" held on November 22, brought together leading medical experts to explore how SPOT-MAS, a technology that integratesmulti-omicscell-free DNA  analysis with AI, can help bridge gaps in traditional screening and make preventive health more accessible.At the event, esteemed guests jointly pressed the ceremonial lighting panel, symbolizing the launch of SPOT-MAS, and introducing the technology as a meaningful contribution to early cancer detection in Taiwan.","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2833590/From_left__Dr_Teng_Chung_Jen_Director_Cancer_Prevention_Treatment_Centre.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2833590/From_left__Dr_Teng_Chung_Jen_Director_Cancer_Prevention_Treatment_Centre.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/spot-mas-launches-in-taiwan-ai-powered-multi-cancer-early-detection-ushers-in-a-new-era-of-precision-medicine-302627958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4108","LU0170899867.USD","LU1165135440.EUR","BK4585","BK4179","LU1861220033.SGD","BK4548","LU1303367103.USD","LU2413666004.HKD","LU1596574779.USD","MAS","LU2362540622.SGD","LU2250418816.HKD","LU1721427968.SGD","LU2098885051.SGD","LU2360107168.USD","NGS","BK7111","LU1543694498.USD","LU1861215975.USD","BK4086","LU0056508442.USD","LU2360106780.USD","LU0786609619.USD","LU1852331112.SGD","LU1804176565.USD","SG9999001440.SGD","LU2290526834.HKD","LU2413665964.HKD","BK4588","SPOT","BK4571","LU1620156213.USD","LU2265009873.SGD","LU2362541273.HKD","LU1983260115.SGD","LU2362541513.USD","NGS.AU","LU1620156130.USD"],"gpt_icon":0},{"id":"2584237869","title":"Nutritional Growth Solutions Announces A$2M Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2584237869","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584237869?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:21","pubTimestamp":1763569314,"startTime":"0","endTime":"0","summary":"Nov 3 (Reuters) - Nutritional Growth Solutions Ltd ::*COMMITMENTS RECEIVED FOR $2M SHARE PLACEMENT*PLACEMENT AT A$0.02 PER SHARE*ALL FIGURES IN AUD*Further company coverage: NGS.AX* ((Reuters.Briefs@t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD9wTZjW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7111","NGS.AU"],"gpt_icon":0},{"id":"2584986111","title":"Nutritional Growth Solutions Ltd-Appointment of New Directors & Expansion of Ngs' Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2584986111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584986111?lang=en_us&edition=fundamental","pubTime":"2025-11-18 14:52","pubTimestamp":1763448749,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nTUE5NYXYK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","NGS.AU"],"gpt_icon":0},{"id":"2584884611","title":"AI and Multi-omics are Transforming Cancer Care: APAC Precision Oncology Conference Outlines the Future of Early Detection and Personalized Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2584884611","media":"prnewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584884611?lang=en_us&edition=fundamental","pubTime":"2025-11-17 13:45","pubTimestamp":1763358300,"startTime":"0","endTime":"0","summary":"HONG KONG, Nov. 17, 2025 /PRNewswire/ -- TheAPAC Precision Oncology Conference 2025, themed Artificial Intelligence  & Multi-omics in Cancer Management, convened in Hong Kong on November 1, marking Lung Cancer Awareness Month with a clear message: AI and multi-omics are no longer theoretical - they are driving real-world advancements in cancer care across the Asia-Pacificregion.The APAC Precision Oncology Conference 2025: 13 Distinguished Faculty Members. Multi-omics integrates diverse layers of biological data—such as DNA fragments, methylation patterns, copy number aberrations, and genetic mutations—to provide a more comprehensive view of cancer cells, not only found in tissue but also in blood samples. When harnessed with AI, these insights enable rapid, accurate analysis, empowering clinicians to detect cancer earlier, tailor personalized treatments, and monitor disease progression with unprecedented precision.","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2824310/The_APAC_Precision_Oncology_Conference_2025___13_distinguished_faculty.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2824310/The_APAC_Precision_Oncology_Conference_2025___13_distinguished_faculty.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/ai-and-multi-omics-are-transforming-cancer-care-apac-precision-oncology-conference-outlines-the-future-of-early-detection-and-personalized-treatment-302616653.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4528","AI","NGS.AU","BK4543","NGS","BK4585","BK4551","BK4588","BK4023","BK7095","BK7111","BK4587","MRD.AU","BK4179"],"gpt_icon":0},{"id":"2583656715","title":"MP Group: Driving Health Innovation and Excellence","url":"https://stock-news.laohu8.com/highlight/detail?id=2583656715","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583656715?lang=en_us&edition=fundamental","pubTime":"2025-11-13 18:08","pubTimestamp":1763028480,"startTime":"0","endTime":"0","summary":"BANGKOK, Nov. 13, 2025 /PRNewswire/ -- MP Group  Co., Ltd., a pioneering force in the Thai healthcare ecosystem, was proudly honored with the Corporate Excellence Award at the Asia Pacific Enterprise Awards  Thailand Chapter, organized by Enterprise Asia. This accolade celebrates the company's remarkable journey, marked by two decades of unwavering commitment to medical innovation, holistic wellness, and empowering the community to \"Live An Excellent Life.\". Founded in 2001, MP Group began as a distributor of medical diagnostic devices and has since evolved into a comprehensive healthcare solutions provider. Today, the company offers an extensive portfolio of over 1,000 SKUs, ranging from rapid diagnostic tests  and clinical automation systems to cutting-edge technologies like next-generation sequencing  for precision medicine. By partnering with over 30 leading global manufacturers, MP Group ensures that healthcare providers nationwide have access to world-class diagnostic tools.Looki","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/mp-group-driving-health-innovation-and-excellence-302614342.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4179","BK7111","NGS","NGS.AU"],"gpt_icon":0},{"id":"2580625559","title":"BRIEF-Nutritional Growth Solutions Announces A$2M Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2580625559","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580625559?lang=en_us&edition=fundamental","pubTime":"2025-11-03 09:35","pubTimestamp":1762133723,"startTime":"0","endTime":"0","summary":"BRIEF-Nutritional Growth Solutions Announces A$2M Share Placement Nov 3 (Reuters) - Nutritional Growth Solutions Ltd NGS.AX:COMMITMENTS RECEIVED FOR $2M SHARE PLACEMENTPLACEMENT AT A$0.02 PER SHAREALL FIGURES IN AUDFurther company coverage: NGS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUE61D6GP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7111","NGS.AU"],"gpt_icon":0},{"id":"2580234485","title":"Nutritional Growth Solutions Ltd-Proposed Issue of Securities - Ngs","url":"https://stock-news.laohu8.com/highlight/detail?id=2580234485","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580234485?lang=en_us&edition=fundamental","pubTime":"2025-11-03 06:56","pubTimestamp":1762124167,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251102:nTUE94Y1ZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGS.AU","BK7111"],"gpt_icon":0},{"id":"2580234489","title":"Nutritional Growth Solutions Ltd-Commitments Received for $2M Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2580234489","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580234489?lang=en_us&edition=fundamental","pubTime":"2025-11-03 06:56","pubTimestamp":1762124162,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251102:nTUE61D6GP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","NGS.AU"],"gpt_icon":0},{"id":"2579160077","title":"Nutritional Growth Solutions Ltd-Quarterly Activities/Appendix 4C Cash Flow Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2579160077","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579160077?lang=en_us&edition=fundamental","pubTime":"2025-10-30 14:37","pubTimestamp":1761806240,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUE3XMRV3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","NGS.AU"],"gpt_icon":0},{"id":"2579868921","title":"BRIEF-Nutritional Growth Solutions Seeks Trading Halt Pending Capital Raising Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2579868921","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579868921?lang=en_us&edition=fundamental","pubTime":"2025-10-29 15:40","pubTimestamp":1761723614,"startTime":"0","endTime":"0","summary":"BRIEF-Nutritional Growth Solutions Seeks Trading Halt Pending Capital Raising AnnouncementOct 29 (Reuters) - Nutritional Growth Solutions Ltd NGS.AX:TRADING HALTSEEKS TRADING HALT PENDING CAPITAL RAISING ANNOUNCEMENTFurther company coverage: NGS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUE77GL69:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGS.AU","BK7111"],"gpt_icon":0},{"id":"2579253929","title":"Nutritional Growth Solutions Ltd-Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2579253929","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579253929?lang=en_us&edition=fundamental","pubTime":"2025-10-29 15:38","pubTimestamp":1761723529,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUE77GL69:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","NGS.AU"],"gpt_icon":0},{"id":"2578696773","title":"Raffles Medical Group Partners Gene Solutions to Expand Access to Global Cancer Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2578696773","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578696773?lang=en_us&edition=fundamental","pubTime":"2025-10-27 13:22","pubTimestamp":1761542520,"startTime":"0","endTime":"0","summary":"SINGAPORE, Oct. 27, 2025 /PRNewswire/ -- Raffles Medical Group  and Gene Solutions have signed a Memorandum of Understanding  on 22 October 2025 to streamline patient recruitment for oncology clinical trials, marking a significant milestone in advancing precision medicine in Southeast Asia.[From left to right] Mr. Wilson Lai, General Manager of Raffles Medical Indochina and Dr. Nguyen Huu Nguyen, Co-founder and Deputy CEO of Gene Solutions.Under this partnership,the Group and Gene Solutions will collaborate to identify patients eligible for pharma-sponsored clinical trials. Patients undergoing Comprehensive Genomic Profiling  via Gene Solutions will be automatically screened for eligibility. The Group's Clinical Trials Unit will collaborate closely with local oncologists to facilitate patient enrolment. This initiative aims to make cutting-edge cancer treatments more accessible and support more equitable access to clinical trials across the region.","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2805483/From_left_right__Mr_Wilson_Lai_General_Manager_Raffles_Medical.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2805483/From_left_right__Mr_Wilson_Lai_General_Manager_Raffles_Medical.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/raffles-medical-group-partners-gene-solutions-to-expand-access-to-global-cancer-clinical-trials-302595012.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6092","MRD.AU","BK7095","NGS.AU","BK4179","BSL.SI","BK7111","NGS","BK6511"],"gpt_icon":0},{"id":"2576014906","title":"Twist Bioscience (TWST): Assessing Valuation After New Sequencing Workflow Collaboration With Element Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2576014906","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576014906?lang=en_us&edition=fundamental","pubTime":"2025-10-18 17:26","pubTimestamp":1760779564,"startTime":"0","endTime":"0","summary":"Twist Bioscience (TWST) has unveiled its new Trinity Freestyle Fast Hybridization workflow in collaboration with Element Biosciences, providing a streamlined sequencing solution for researchers. The expanded agreement grants Twist exclusive access to this workflow, strengthening its position in genomics.\nSee our latest analysis for Twist Bioscience.\nWhile the enhanced partnership with Element Biosciences highlights Twist Bioscience’s innovative push in genomics, the market reaction has been...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/twist-bioscience-twst-assessing-valuation-after-new-sequenci","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/twist-bioscience-twst-assessing-valuation-after-new-sequenci","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TWST","NGS","BK4588","BK4585","BK4139","BK7111","NGS.AU","BK4179"],"gpt_icon":0},{"id":"2575767330","title":"Gene Solutions Brings Insights on Advances in MRD and Multi-Omics Technologies to the Singapore Society of Oncology Annual Scientific Meeting 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2575767330","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575767330?lang=en_us&edition=fundamental","pubTime":"2025-10-16 10:30","pubTimestamp":1760581800,"startTime":"0","endTime":"0","summary":"SINGAPORE, Oct. 15, 2025 /PRNewswire/ -- What if cancer care could move from reactive to proactive?At the Singapore Society of Oncology Annual Scientific Meeting 2025 , Gene Solutions showcased how Molecular Residual Disease  and AI-powered multi-omics technologies are advancing precision oncology across Asia-Pacific, reinforcing Singapore's role as a hub for innovation and global collaboration.The symposium, \"Advancing Precision Oncology: MRD and Multi-Omics in Solid Tumors,\" gathered leading oncologists and molecular biology experts to explore how ctDNA-MRD and multi-omics support clinicians and researchers in Singapore and across the Asia-Pacific.MRD assays analyze circulating tumor DNA  in the blood to monitor cancer at the molecular level. Experts discussed how this approach may:. Unlike single-modality tests, Gene Solutions' platform integrates DNA, RNA, and AI-enhanced multi-omics signals for comprehensive tumor profiling and personalized ctDNA monitoring. This multi-omics appro","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/gene-solutions-brings-insights-on-advances-in-mrd-and-multi-omics-technologies-to-the-singapore-society-of-oncology-annual-scientific-meeting-2025-302585716.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRD.AU","NGS","BK7111","BK7095","NGS.AU","BK4179"],"gpt_icon":0},{"id":"2575473303","title":"How Investors Are Reacting To Twist Bioscience (TWST) Gaining Exclusive Access to Advanced Sequencing Workflow","url":"https://stock-news.laohu8.com/highlight/detail?id=2575473303","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575473303?lang=en_us&edition=fundamental","pubTime":"2025-10-15 19:23","pubTimestamp":1760527387,"startTime":"0","endTime":"0","summary":"On October 6, 2025, Element Biosciences and Twist Bioscience announced the launch of the new Trinity Freestyle Fast Hybridization workflow for Element’s AVITI sequencing platforms, providing a rapid, scalable, and user-friendly solution for genomic researchers.\nThis expanded agreement gives Twist Bioscience exclusive access to the workflow with its entire lineup of library preparation kits, potentially enhancing compatibility and reinforcing the appeal of Twist’s synthetic DNA technology to...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/how-investors-are-reacting-to-twist-bioscience-twst-gaining","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/how-investors-are-reacting-to-twist-bioscience-twst-gaining","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4588","BK4585","NGS","TWST","BK7111","ISBC","BK4179","BK4211","NGS.AU"],"gpt_icon":0},{"id":"2572536201","title":"Gene Solutions and AMPATH Launch Advanced Genomics Laboratory in Hyderabad to Expand Access to Precision Medicine in India","url":"https://stock-news.laohu8.com/highlight/detail?id=2572536201","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572536201?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:01","pubTimestamp":1759320060,"startTime":"0","endTime":"0","summary":"HYDERABAD, India, Oct. 1, 2025 /PRNewswire/ -- Gene Solutions, a leading genetic testing innovator in Asia, has partneredwith AMPATH , a trusted provider of high-quality diagnostic services in India, to open a new advanced genomics laboratory in Hyderabad. This collaboration aimsto bring high-value, next-generation sequencing  technologies closer to patients and healthcare providers across the country.Dr. Nguyen Hoai Nghia, Co-founder and CEO of Gene Solutions , and Dr. Maneesh Bagai, COO of AMPATH , exchange the signed Memorandum of Understanding .By combining AMPATH's extensive diagnostic network with Gene Solutions' expertise in genomics, the partnership will enable more timely, accessible, and informative testing in key areas such as reproductive health, cancer screening, and personalized medicine.Supporting Better Patient Care Through Advanced Testing The collaboration between Gene Solutions and Ampath introduces advanced diagnostic tools that support more informed clinical decisi","market":"us","thumbnail":"https://mma.prnewswire.com/media/2786650/Dr_Nguyen_Hoai_Nghia_Co_founder_CEO_Gene_Solutions__sixth_left.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2786650/Dr_Nguyen_Hoai_Nghia_Co_founder_CEO_Gene_Solutions__sixth_left.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/gene-solutions-and-ampath-launch-advanced-genomics-laboratory-in-hyderabad-to-expand-access-to-precision-medicine-in-india-302572384.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGS.AU","BK6088","MNDmain","BK6522","NGS","BK4179","BLZ.SI","BK7111"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}]}}